Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine targeting serogroups A, C, W, Y, and X when co-administered with routine childhood vaccines at ages 9 months and 15 months in Mali: a single-centre, double-blind, randomised, controlled, phase 3, non-inferiority trial
Emory University
Fatoumata Diallo; Fadima C Haidara; Milagritos D Tapia; Clara P Dominguez Islas; Mark R Alderson; William P Hausdorff; Lionel Martellet; Nancy Hosken; Dhananjay Kapse; Prasad S Kulkarni; Kelly Townsend-Payne; Francesca Vanni; Christine M Posavad; Samba O Sow; Karen L Kotloff; Wilbur H Chen; NmCV-5 EPI study team
IDCRC Statistical and Data Science Unit, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.